Klaus joins Epitopea after serving as Chief Development Officer (CDO) at Nykode Therapeutics, where he oversaw clinical development, regulatory affairs, and project management across oncology, ...

Getting into Harvard requires meticulous preparation and a thorough understanding of its application process. About 30% of ...

ACLF clinical trials expected to initiate in 1Q253 clinical data readouts expected by year-end 2025 across the ACLF pipeline, including ...

Oxford and Cambridge have some big strengths. The two university cities outstrip most other innovation clusters on scientific ...

But they are far too small, and they do not have access to the workers who would help turn great ideas into flourishing ...

Rakesh Ramchurn reports on an exhibition exploring how Islamic art influenced the work of the pioneering British designer ...

Uzbekistan, host of the upcoming 20th meeting of the Conference of the Parties (COP20) to the Convention on International ...